Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LncRNAs and CircRNAs in cancer
Xin Yin, Huiran Lin, Lei Lin, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 24

Showing 24 citing articles:

Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms
Fei Li, Zaosong Zheng, Wei Chen, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100938-100938
Closed Access | Times Cited: 98
Epigenetic modification of m6A regulator proteins in cancer
Yumin Wang, Yan Wang, Harsh Patel, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 81
crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer
Yutian Zou, Anli Yang, Bo Chen, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101126-101126
Closed Access | Times Cited: 23
Advanced approaches of the use of circRNAs as a replacement for cancer therapy
Goran Sedeeq Hama Faraj, Bashdar Mahmud Hussen, Snur Rasool Abdullah, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 3, pp. 811-830
Open Access | Times Cited: 10
Long non-coding RNAs in cancer: multifaceted roles and potential targets for immunotherapy
Lokesh Kadian, Deepika Verma, Neelam Lohani, et al.
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 12, pp. 3229-3254
Closed Access | Times Cited: 8
Insights into the Role of LncRNAs and miRNAs in Glioma Progression and Their Potential as Novel Therapeutic Targets
Mateusz Kciuk, Esam Bashir Yahya, Montaha Mohamed Ibrahim Mohamed, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3298-3298
Open Access | Times Cited: 19
The role of the methyltransferase METTL3 in prostate cancer: a potential therapeutic target
Xuming Zhou, Keqiang Chai, Hezhen Zhu, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Cell Cycle-Related lncRNAs as Innovative Targets to Advance Cancer Management
Xiao-Ru Liang, Yanfei Liu, Feng Chen, et al.
Cancer Management and Research (2023) Vol. Volume 15, pp. 547-561
Open Access | Times Cited: 13
Development of a prognostic Neutrophil Extracellular Traps related lncRNA signature for soft tissue sarcoma using machine learning
Binfeng Liu, Shasha He, Chenbei Li, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 3
Combination MEG3 lncRNA and Ciprofloxacin dramatically decreases cell migration and viability as well as induces apoptosis in GC cells in vitro
Dena Najafi, Goli Siri, Maryam Sadri, et al.
Biotechnology and Applied Biochemistry (2024) Vol. 71, Iss. 4, pp. 809-816
Closed Access | Times Cited: 3
Comprehensive landscape and future perspective of long noncoding RNAs in non-small cell lung cancer: it takes a village
Yong-Qiang Ao, Jian Gao, Jiahao Jiang, et al.
Molecular Therapy (2023) Vol. 31, Iss. 12, pp. 3389-3413
Open Access | Times Cited: 8
The pathogenic roles of lncRNA-Taurine upregulated 1 (TUG1) in colorectal cancer
Shirin Azizidoost, Ava Nasrolahi, Farhoodeh Ghaedrahmati, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 13
MicroRNAs, Tristetraprolin Family Members and HuR: A Complex Interplay Controlling Cancer-Related Processes
Cyril Sobolewski, Laurent Dubuquoy, Noémie Legrand
Cancers (2022) Vol. 14, Iss. 14, pp. 3516-3516
Open Access | Times Cited: 11
Functions, mechanisms, and therapeutic implications of noncoding RNA in acute myeloid leukemia
Xiaokang Wang, Yong Tong, Tianrong Xun, et al.
Fundamental Research (2023)
Open Access | Times Cited: 5
Dysregulation of circular RNAs in inflammation and cancers
Jiayu Liu, Fangqing Zhao, Ling‐Ling Chen, et al.
Fundamental Research (2023) Vol. 3, Iss. 5, pp. 683-691
Open Access | Times Cited: 4
Decoding the Promise and Challenges of miRNA-Based Cancer Therapies: An Essential Update on miR-21, miR-34, and miR-155
Hongbo Qian, Mazaher Maghsoudloo, Parham Jabbarzadeh Kaboli, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 14, pp. 2781-2798
Open Access | Times Cited: 1
Disrupting of IGF2BP3-stabilized HK2 mRNA by MYO16-AS1 competitively binding impairs LUAD migration and invasion
Peiwei Li, Haibo Ge, Jiangfeng Zhao, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 10, pp. 2795-2808
Open Access | Times Cited: 3
Identification of RP11‐770J1.4 as immune‐related lncRNA regulating the CTXN1–cGAS–STING axis in histologically lower‐grade glioma
Qiyuan Zhuang, Chaxian Liu, Yihan Hu, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 3
Development and Evaluation of a Novel Cuproptosis‐Related lncRNA Signature for Gastric Cancer Prognosis
Chunlin Yin, Ming Gao, Qi Wang, et al.
Computational and Mathematical Methods in Medicine (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 2
Epigenetic biomarkers in neuropsychiatric disorders
Dennis R. Grayson, Jacob Peedicayil
Elsevier eBooks (2024), pp. 37-49
Closed Access
Functional Roles of Long Non-coding RNAs on Stem Cell-related Pathways in Glioblastoma
Arya Moftakhar, Seyed Esmaeil Khoshnam, Maryam Farzaneh, et al.
Current Signal Transduction Therapy (2024) Vol. 19, Iss. 3
Closed Access
CARM1-induced lncRNA NEAT1 synchronously activates MYCN and GalNAcT-I to accelerate the progression of neuroblastoma
Zhigang Hu, Weili Xu, Huiming Wang, et al.
Gene (2024) Vol. 938, pp. 149164-149164
Closed Access
A Novel Differentially Expressed Cuproptosis-Related lncRNAs Signature to predict the prognosis and immune characteristics of hepatocellular carcinoma
Chunlin Yin, Ming Gao, Yuansong Sun, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top